// App-Quantinova.ai

4267 : The Impact of Myeloproliferative Neoplasms (MPNs) on Patients' Quality of Life and Productivity: Results from the International MPN Landmark Survey

Researchers

Presenter

  • Claire N. Harrison

Principal Investigators

  • Steffen Koschmieder

  • Lynda Foltz

  • Gavin Taylor-Stokes

  • John Waller

  • Ruben A. Mesa

  • Paola Guglielmelli

  • Tina Flindt

  • Michael Koehler

  • Jonathan Mathias

  • Norio Komatsu

  • Robert N. Boothroyd

  • Amber Spierer

  • Julian Perez Ronco

Medical Centers

  • Adelphi Real World, Bollington, United Kingdom

  • Patient Chair, MPN Voice, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Mayo Clinic, Scottsdale, AZ

  • Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan

  • St. Pauls Hospital, University of British Columbia, Vancouver, BC, Canada

  • Patient advocate, Prato, Italy

  • Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany

  • Department of Hematology/Oncology, Otto-von-Guericke University, Magdeburg, Germany

  • CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Locations

  • Canada

  • Japan

  • Italy

  • Germany

  • United Kingdom

  • United States

Companies

  • Novartis AG

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Polycythemia vera

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved